1. What Is the Point of Care Diagnostics Market?
The Point of Care Diagnostics Market covers the medical tests performed at or near the patient's location outside the central laboratory, supplying rapid diagnostic results to clinical settings including emergency departments, physician offices, wards, and community health facilities. Clinicians use point-of-care diagnostics to make immediate treatment decisions without waiting for central laboratory turnaround. The market serves rapid infectious disease testing, blood glucose, cardiac biomarkers, blood gas and electrolytes, coagulation, urinalysis, and pregnancy testing across hospital and community settings. It includes the analysers, test cartridges or strips, and the data connectivity that links results to electronic health records, with demand driven by the clinical value of rapid results in emergency and acute care settings.
2. Point of Care Diagnostics Market Size & Forecast
3. Emerging Technologies
- Molecular point-of-care platforms delivering PCR-quality respiratory and infectious disease results in under an hour.
- High-sensitivity troponin cartridge tests enabling rapid myocardial infarction rule-out in emergency departments.
- Blood gas and electrolyte analysers providing critical care results without specimen transport.
- Connectivity solutions transmitting point-of-care results directly to electronic health records.
Comparable technologies are influencing adjacent market segments in similar ways. Read more in our Companion Diagnostics Market.
4. Key Market Opportunity
The largest near-term opportunity in the Point of Care Diagnostics market lies in emergency departments adopting molecular respiratory panels for same-visit influenza and COVID diagnosis and treatment. A second, faster-growing opportunity lies in primary care clinicians using rapid antigen and molecular tests for immediate infectious disease diagnosis. As adoption broadens, the addressable opportunity is expanding from early deployments toward wider commercial use, with North America positioned for the most rapid growth through 2034.
5. Top Companies in the Point of Care Diagnostics Market
The following organisations hold leading positions in the Point of Care Diagnostics Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Abbott
- Roche
- Danaher (Cepheid)
- Quidel (QuidelOrtho)
- Siemens Healthineers
- bioMerieux
- Becton Dickinson
- LifeScan (OneTouch)
- Bayer
- Hologic
6. Market Segmentation
The Point of Care Diagnostics Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Technology | Immunoassay Strip and CartridgeMolecular POCElectrochemicalOptical |
| By Application | Infectious DiseaseCardiologyEndocrinologyBlood GasCoagulation |
| By Setting | Emergency DepartmentPhysician OfficeHomeCommunity |
| By Geography | North AmericaEuropeAsia PacificLatin AmericaMiddle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Point of Care Diagnostics Market trajectory over the forecast period:
Respiratory and Infectious Disease Point-Of-Care Testing Expanded Rapidly Following the Pandemic.Respiratory and infectious disease point-of-care testing expanded rapidly following the pandemic, as investment in rapid influenza, COVID-19, respiratory syncytial virus, and combination respiratory panel tests created a broadly deployed infrastructure for rapid pathogen detection. Abbott's ID NOW, Roche's cobas Liat, and Cepheid's GeneXpert provided near-PCR-quality molecular results at point of care. This molecular point-of-care capability has changed the expectation for what bedside testing can deliver, with clinicians now expecting molecular-quality rapid results that immunoassay strips previously could not achieve. The infrastructure built for respiratory testing is being leveraged for additional applications.
Blood Glucose Home Monitoring Has Been the Largest-Volume Point-Of-Care Application for Decades.Blood glucose home monitoring has been the largest-volume point-of-care application for decades, with billions of test strips dispensed annually to diabetic patients. The transition toward continuous glucose monitoring is reducing the frequency of traditional fingerstick testing in insulin-dependent diabetes, moderating strip market growth. This substitution dynamic is structural and ongoing.
Cardiac Point-Of-Care Testing for Troponin Enables Rapid Rule-Out of Myocardial Infarction in Emergency Departments.Cardiac point-of-care testing for troponin enables rapid rule-out of myocardial infarction in emergency departments, allowing discharge decisions for low-risk patients and reducing emergency overcrowding. The high sensitivity of current point-of-care troponin assays approaches central laboratory platforms for diagnostic accuracy.
For related market intelligence, see the In Vitro Diagnostics Market.
8. Segmental Analysis
By technology, the immunoassay strip and cartridge segment dominated the Point of Care Diagnostics Market in 2025, as rapid antigen and blood glucose strips represent the highest-volume point-of-care testing by unit.
By application, the infectious disease segment is projected to register the highest CAGR in the Point of Care Diagnostics Market through 2034, as molecular respiratory and STI panel testing expands the infectious disease POC indication base, driving the fastest-growing application category within the market.
9. Regional Analysis
Regional demand patterns across the Point of Care Diagnostics Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
Asia Pacific dominated the Point of Care Diagnostics Market in 2025, accounting for the largest share by volume. Moreover, China and India represent the largest markets for blood glucose monitoring and rapid antigen testing by unit volume. In addition, domestic Chinese makers supply high-volume, cost-accessible test strips and antigen tests for the large diabetic and infectious disease testing population. The scale of the patient population drives high-volume testing demand This volume base anchors regional dominance.
Highest CAGR Region
North America is projected to register the highest CAGR in the Point of Care Diagnostics Market through 2034. The primary driver is the expansion of molecular point-of-care testing from respiratory into additional infectious disease, sexually transmitted infection, and oncology applications in US physician offices and urgent care settings. Moreover, high-sensitivity troponin and direct-to-consumer testing expand the US point-of-care market beyond hospital settings. The combination of these demand drivers and an expanding base positions North America for sustained growth outperformance through 2034.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Point of Care Diagnostics Market was valued at USD 28.47 Bn in 2025 and is projected to reach USD 66.05 Bn by 2034, growing at a CAGR of 9.8% over the 2026–2034 forecast period.
The Point of Care Diagnostics Market is projected to grow at a CAGR of 9.8% from 2026 to 2034.
Asia Pacific dominated the Point of Care Diagnostics Market in 2025, accounting for the largest share by volume.
The leading companies in the Point of Care Diagnostics Market include Abbott, Roche, Danaher (Cepheid), Quidel (QuidelOrtho), Siemens Healthineers, bioMerieux, Becton Dickinson, LifeScan (OneTouch), Bayer, Hologic.
Respiratory and infectious disease point-of-care testing expanded rapidly following the pandemic.
By technology, the immunoassay strip and cartridge segment dominated the Point of Care Diagnostics Market in 2025, as rapid antigen and blood glucose strips represent the highest-volume point-of-care testing by unit.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.